Suzhou Novoprotein Scientific Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 264.55 million compared to CNY 341.9 million a year ago. Net income was CNY 90.42 million compared to CNY 149.01 million a year ago.

Basic earnings per share from continuing operations was CNY 1.59 compared to CNY 3.73 a year ago. Diluted earnings per share from continuing operations was CNY 1.59 compared to CNY 3.73 a year ago.